Sorted By:

Relevance


Highlighting innovation during Mental Illness Awareness Week 2015

PhRMA  |  Blog Post

As our knowledge of the brain continues to expand, biopharmaceutical scientists are finding new, exciting ways to help patients facing depression, schizophrenia and many other disorders .
http://catalyst.phrma.org/highlighting-innovation-during-mental-illness-awareness-week-2015

Medicare Monday: Research Finds Access to Medicare Prescription Drug Coverage Improved Health Outcomes, Significantly Reducing Depressive Symptoms Among Seniors

PhRMA  |  Blog Post

Today, there are more medicines in development to treat depression – 34 – than there were prior to the implementation of Part D.
http://catalyst.phrma.org/medicare-monday-research-finds-access-to-medicare-prescription-drug-coverage-improved-health-outcomes-significantly-reducing-depressive-symptoms-among-seniors

Why Cross-Country Comparisons on Drug Prices are Misleading

PhRMA  |  Blog Post

Most cross-country comparisons focus solely on the list prices of medicines and exclude from calculations the steep discounts that are required in U.S. public programs such as Medicaid and the rebates negotiated by insurers and pharmacy benefit managers.
http://catalyst.phrma.org/why-cross-country-comparisons-on-drug-prices-are-misleading

4 facts on why drug importation is bad for patients

PhRMA  |  Blog Post

It has become very easy for counterfeiters to make bottles and packages look genuine, but the reality is they are often filled with laced, adulterated or fake pills that are dangerous to patients. 
http://catalyst.phrma.org/4-facts-on-why-drug-importation-is-bad-for-patients

Medicare Monday: 3 tips for choosing a Medicare Part D plan

PhRMA  |  Blog Post

Here are 3 things to keep in mind when picking a Part D plan:
http://catalyst.phrma.org/medicare-monday-3-tips-for-choosing-a-medicare-part-d-plan

Welcome to the new PhRMA.org

PhRMA  |  Blog Post

Browse through an expansive collection of blog posts, graphics, videos, fact sheets and reports in the Resource Library.
http://catalyst.phrma.org/welcome-to-the-new-phrma.org

ICYMI: New cholesterol-lowering medicines will not be “budget busters”

PhRMA  |  Blog Post

Read more about how our nation's competitive biopharmaceutical marketplace controls costs while encouraging the development of new treatments and cures here.
http://catalyst.phrma.org/icymi-new-cholesterol-lowering-medicines-will-not-be-budget-busters

Many Patients with Exchange Coverage to Pay More than Twice As Much Out Of Pocket for Prescriptions Compared to Employer Plans

PhRMA  |  Press Release

A graphic on the study’s findings is available here.
https://www.phrma.org/press-release/many-patients-with-exchange-coverage-to-pay-more-than-twice-as-much-out-of-pocket-for-prescriptions-compared-to-employer-plans

What makes Valeant different than innovative biopharmaceutical companies?

PhRMA  |  Blog Post

According to the National Science Foundation, the sector is the single largest funder of business R&D in the U.S., representing about one in every five dollars spent on domestic R&D by U.S. businesses.
http://catalyst.phrma.org/what-makes-valeant-different-than-innovative-biopharmaceutical-companies

Many Patients with Exchange Coverage to Pay More than Twice As Much Out Of Pocket for Prescriptions Compared to Employer Plans

PhRMA  |  Press Release

A graphic on the study’s findings is available here.
https://www.phrma.org

Medicare Monday: Medicare Part D & Adherence Help High Cholesterol Patients Save

PhRMA  |  Blog Post

Journal of Managed Care and Specialty Pharmacy, increasing the number of prescriptions filled for dyslipidemia decreases non-pharmacy medical costs, as illustrated in the graphic below.
http://catalyst.phrma.org/medicaremonday-medicare-part-d-adherence-help-high-cholesterol-patients-save

The Best Kind of Progress: Cancer Medicines and the Value They Bring to Us All

PhRMA  |  Blog Post

According to a recent analysis, 75 percent of exchange insurance plans subject cancer medicines to coinsurance, which could result in the first month.
http://catalyst.phrma.org/the-best-kind-of-progress-cancer-medicines-and-the-value-they-bring-to-us-all

Special Edition Medicare Monday: More context on MedPAC’s analysis of drug costs – Part II

PhRMA  |  Blog Post

Overall, MedPAC’s presentation of the data comparing retail drug spending in Medicare vs.
http://catalyst.phrma.org/special-edition-medicare-monday-more-context-on-medpacs-analysis-of-drug-costs-part-ii

3 Tiers, 4 Tiers, 5 Tiers and More – A look at tiering in health insurance exchange plans

PhRMA  |  Blog Post

So why does the number of tiers matter?
http://catalyst.phrma.org/3-tiers-4-tiers-5-tiers-and-more-a-look-at-tiering-in-health-insurance-exchange-plans

PhRMA Statement About Accessing Online Health Information - 2009

PhRMA  |  Press Release

Such a graphic symbol could be combined with a universal warning statement to provide an indication of risk when there is little space (e.g.
https://www.phrma.org/press-release/phrma-statement-about-accessing-online-health-information-2009

Scientists Open The ‘Black Box’ of Schizophrenia With Dramatic Genetic Discovery

From Hope To Cures  |  From Our Network

One area in particular, when graphed, showed the strongest association.
http://www.fromhopetocures.org/scientists-open-the-black-box-of-schizophrenia-with-dramatic-genetic-discovery

340B Spotlight: New Charity Care Data Shows Most Hospitals with Contract Pharmacies Provide Little Charity Care

PhRMA  |  Blog Post

  In addition to this data, a recent Department of Health and Human Services Office of the Inspector General report found most of the 15 DSH hospitals they sampled did not pass along the 340B discounts to uninsured patients.
http://catalyst.phrma.org/340b-spotlight-new-charity-care-data-shows-most-hospitals-with-contract-pharmacies-provide-little-charity-care

A new kind of Chart Pack

PhRMA  |  Blog Post

PhRMA’s chart pack reports are shareable decks of graphs and charts that highlight advances in R&D and treatment, spending and economic data, and broad outcomes and savings for different parts of the health care sphere.
http://catalyst.phrma.org/a-new-kind-of-chart-pack

World Asthma Day: New Hope for Millions with Asthma

PhRMA  |  Blog Post

As this infographic demonstrates, health insurance exchange plans  may impose a high out-of-pocket cost burden on asthma patients.
http://catalyst.phrma.org/world-asthma-day-new-hope-for-millions-with-asthma

How We’re Curing The Incurable

PhRMA  |  Blog Post

Without the availability of new hepatitis C treatments, total annual medical costs for this population are projected to nearly triple over the next 20 years: from $30 billion to $85 billion.
http://catalyst.phrma.org/how-were-curing-the-incurable

Biopharmaceutical industry has made progress in cancer fight, continues work toward moonshot

PhRMA  |  Blog Post

@SteveUbl: We've made tremendous progress, but our commitment continues in work toward #cancermoonshot http://onphr.ma/1W8GltB" data-constrained="true" src="http://clicktotweet.com/img/tweet-graphic-4.png" style="width: 70px;" title="Tweet: .
http://catalyst.phrma.org/biopharmaceutical-industry-has-made-progress-in-cancer-fight-continues-work-toward-moonshot

You have reviewed the first 171 results out of 171. Each page contains 25 results. You're on page 7.

prev 7 next